15(R)-15-methyl Prostaglandin E2 |
A prodrug for the potent PGE2 analog 15(S)-15-methyl PGE2 designed for act… |
1 mg |
14725-1 |
More Info
|
15(R)-15-methyl Prostaglandin E2 |
A prodrug for the potent PGE2 analog 15(S)-15-methyl PGE2 designed for act… |
500 µg |
14725-500 |
More Info
|
15(R)-15-methyl Prostaglandin F2α |
A prodrug analog of 15(S)-15-methyl PGF2α designed for activation by… |
1 mg |
16730-1 |
More Info
|
15(R)-15-methyl Prostaglandin F2α |
A prodrug analog of 15(S)-15-methyl PGF2α designed for activation by… |
500 µg |
16730-500 |
More Info
|
15(R)-15-methyl Prostaglandin F2α methyl ester |
15(R)-15-methyl PGF2α methyl ester is a lipid soluble prodrug form o… |
1 mg |
16734-1 |
More Info
|
15(R)-15-methyl Prostaglandin F2α methyl ester |
15(R)-15-methyl PGF2α methyl ester is a lipid soluble prodrug form o… |
500 µg |
16734-500 |
More Info
|
(R)-MG132 |
A potent, reversible, and cell permeable proteasome inhibitor; a more effe… |
1 mg |
13697-1 |
More Info
|
(R)-MG132 |
A potent, reversible, and cell permeable proteasome inhibitor; a more effe… |
10 mg |
13697-10 |
More Info
|
(R)-MG132 |
A potent, reversible, and cell permeable proteasome inhibitor; a more effe… |
25 mg |
13697-25 |
More Info
|
(R)-MG132 |
A potent, reversible, and cell permeable proteasome inhibitor; a more effe… |
5 mg |
13697-5 |
More Info
|
R-(−)-α-Methylhistamine (hydrochloride) |
A histamine H3 receptor agonist; inhibits the release of histamine induced… |
1 mg |
25601-1 |
More Info
|
R-(−)-α-Methylhistamine (hydrochloride) |
A histamine H3 receptor agonist; inhibits the release of histamine induced… |
10 mg |
25601-10 |
More Info
|
R-(−)-α-Methylhistamine (hydrochloride) |
A histamine H3 receptor agonist; inhibits the release of histamine induced… |
25 mg |
25601-25 |
More Info
|
R-(−)-α-Methylhistamine (hydrochloride) |
A histamine H3 receptor agonist; inhibits the release of histamine induced… |
5 mg |
25601-5 |
More Info
|
R-(−)-Deprenyl (hydrochloride) |
A selective, reversible inhibitor of MAO-B (Ki = 0.091 µM) over MAO-… |
1 g |
15046-1 |
More Info
|
R-(−)-Deprenyl (hydrochloride) |
A selective, reversible inhibitor of MAO-B (Ki = 0.091 µM) over MAO-… |
100 mg |
15046-100 |
More Info
|
R-(−)-Deprenyl (hydrochloride) |
A selective, reversible inhibitor of MAO-B (Ki = 0.091 µM) over MAO-… |
250 mg |
15046-250 |
More Info
|
R-(−)-Deprenyl (hydrochloride) |
A selective, reversible inhibitor of MAO-B (Ki = 0.091 µM) over MAO-… |
500 mg |
15046-500 |
More Info
|
(R)-(−)-3,4-MDMA (hydrochloride) |
An analytical reference standard categorized as an amphetamine; the inacti… |
1 mg |
33956-1 |
More Info
|
(R)-(−)-Metalaxyl-d6 |
An internal standard for the quantification of (R)-(−)-metalaxyl by… |
1 mg |
39575-1 |
More Info
|
(R)-(−)-Metalaxyl-d6 |
An internal standard for the quantification of (R)-(−)-metalaxyl by… |
10 mg |
39575-10 |
More Info
|
(R)-(−)-Metalaxyl-d6 |
An internal standard for the quantification of (R)-(−)-metalaxyl by… |
5 mg |
39575-5 |
More Info
|
(R)-Modafinil |
An analytical reference standard categorized as a nootropic and stimulant;… |
1 mg |
29910-1 |
More Info
|
(R)-Modafinil |
An analytical reference standard categorized as a nootropic and stimulant;… |
10 mg |
29910-10 |
More Info
|
(R)-Modafinil |
An analytical reference standard categorized as a nootropic and stimulant;… |
5 mg |
29910-5 |
More Info
|
RN-1734 |
A TRPV4 antagonist (IC50s = 2.3, 5.9, and 3.2 µM for human, mouse, a… |
10 mg |
24205-10 |
More Info
|
RN-1734 |
A TRPV4 antagonist (IC50s = 2.3, 5.9, and 3.2 µM for human, mouse, a… |
25 mg |
24205-25 |
More Info
|
RN-1734 |
A TRPV4 antagonist (IC50s = 2.3, 5.9, and 3.2 µM for human, mouse, a… |
5 mg |
24205-5 |
More Info
|
RN-1747 |
A TRPV4 agonist; selectively induces calcium influx in HEK293 cells expres… |
10 mg |
37573-10 |
More Info
|
RN-1747 |
A TRPV4 agonist; selectively induces calcium influx in HEK293 cells expres… |
25 mg |
37573-25 |
More Info
|
RN-1747 |
A TRPV4 agonist; selectively induces calcium influx in HEK293 cells expres… |
5 mg |
37573-5 |
More Info
|
RN-1747 |
A TRPV4 agonist; selectively induces calcium influx in HEK293 cells expres… |
50 mg |
37573-50 |
More Info
|
RN-18 |
An HIV-1 Vif inhibitor; inhibits Vif-mediated degradation of the DNA editi… |
1 mg |
23331-1 |
More Info
|
RN-18 |
An HIV-1 Vif inhibitor; inhibits Vif-mediated degradation of the DNA editi… |
10 mg |
23331-10 |
More Info
|
RN-18 |
An HIV-1 Vif inhibitor; inhibits Vif-mediated degradation of the DNA editi… |
25 mg |
23331-25 |
More Info
|
RN-18 |
An HIV-1 Vif inhibitor; inhibits Vif-mediated degradation of the DNA editi… |
5 mg |
23331-5 |
More Info
|
RN-486 |
A selective BTK inhibitor (Kds = 0.31 nM; IC50 = 4 nM); produces anti-infl… |
1 mg |
20536-1 |
More Info
|
RN-486 |
A selective BTK inhibitor (Kds = 0.31 nM; IC50 = 4 nM); produces anti-infl… |
10 mg |
20536-10 |
More Info
|
RN-486 |
A selective BTK inhibitor (Kds = 0.31 nM; IC50 = 4 nM); produces anti-infl… |
5 mg |
20536-5 |
More Info
|
RN-1 (hydrochloride) |
A potent, irreversible inhibitor of LSD1 (IC50 = 70 nM); penetrates the bl… |
1 mg |
18124-1 |
More Info
|
RN-1 (hydrochloride) |
A potent, irreversible inhibitor of LSD1 (IC50 = 70 nM); penetrates the bl… |
10 mg |
18124-10 |
More Info
|
RN-1 (hydrochloride) |
A potent, irreversible inhibitor of LSD1 (IC50 = 70 nM); penetrates the bl… |
5 mg |
18124-5 |
More Info
|
RN-9893 (hydrochloride) |
A TRPV4 antagonist (IC50s = 0.42 and 0.66 µM, respectively, for huma… |
1 mg |
29172-1 |
More Info
|
RN-9893 (hydrochloride) |
A TRPV4 antagonist (IC50s = 0.42 and 0.66 µM, respectively, for huma… |
5 mg |
29172-5 |
More Info
|
(R)-nitro-Blebbistatin |
A more stable form of (+)-blebbistatin, the inactive form of blebbistatin;… |
1 mg |
9001935-1 |
More Info
|
(R)-nitro-Blebbistatin |
A more stable form of (+)-blebbistatin, the inactive form of blebbistatin;… |
10 mg |
9001935-10 |
More Info
|
(R)-nitro-Blebbistatin |
A more stable form of (+)-blebbistatin, the inactive form of blebbistatin;… |
5 mg |
9001935-5 |
More Info
|
9(R)-11-nor-9-carboxy-Δ6a,10a-THC |
An analytical reference standard that is structurally similar to known phy… |
1 mg |
38237-1 |
More Info
|
9(R)-11-nor-9-carboxy-Δ6a,10a-THC |
An analytical reference standard that is structurally similar to known phy… |
500 µg |
38237-500 |
More Info
|
(R)-Norketamine (hydrochloride) |
An analytical reference standard categorized as an arylcyclohexylamine; an… |
1 mg |
37821-1 |
More Info
|
(R)-Norketamine (hydrochloride) |
An analytical reference standard categorized as an arylcyclohexylamine; an… |
5 mg |
37821-5 |
More Info
|
Ro 01-6128 |
A positive allosteric modulator of mGluR1; potentiates glutamate-induced c… |
1 mg |
11991-1 |
More Info
|
Ro 01-6128 |
A positive allosteric modulator of mGluR1; potentiates glutamate-induced c… |
10 mg |
11991-10 |
More Info
|
Ro 01-6128 |
A positive allosteric modulator of mGluR1; potentiates glutamate-induced c… |
5 mg |
11991-5 |
More Info
|
Ro 0335 |
An NNRTI and active metabolite of elsulfavirine; inhibits HIV-1 reverse tr… |
10 mg |
36124-10 |
More Info
|
Ro 0335 |
An NNRTI and active metabolite of elsulfavirine; inhibits HIV-1 reverse tr… |
100 mg |
36124-100 |
More Info
|
Ro 0335 |
An NNRTI and active metabolite of elsulfavirine; inhibits HIV-1 reverse tr… |
5 mg |
36124-5 |
More Info
|
Ro 0335 |
An NNRTI and active metabolite of elsulfavirine; inhibits HIV-1 reverse tr… |
50 mg |
36124-50 |
More Info
|
Ro 08-2750 |
A p75NTR ligand; completely inhibits NGF binding to p75NTR in PC12 cells a… |
1 mg |
28772-1 |
More Info
|
Ro 08-2750 |
A p75NTR ligand; completely inhibits NGF binding to p75NTR in PC12 cells a… |
10 mg |
28772-10 |
More Info
|
Ro 08-2750 |
A p75NTR ligand; completely inhibits NGF binding to p75NTR in PC12 cells a… |
5 mg |
28772-5 |
More Info
|
Ro 106-9920 |
A small molecule inhibitor of NF-κB-dependent expression of TNF-&alp… |
1 mg |
15373-1 |
More Info
|
Ro 106-9920 |
A small molecule inhibitor of NF-κB-dependent expression of TNF-&alp… |
10 mg |
15373-10 |
More Info
|
Ro 106-9920 |
A small molecule inhibitor of NF-κB-dependent expression of TNF-&alp… |
5 mg |
15373-5 |
More Info
|
Ro 20-1724 |
A cell-permeable, selective PDE4 inhibitor (IC50 = 2 µM); inhibits t… |
100 mg |
18272-100 |
More Info
|
Ro 20-1724 |
A cell-permeable, selective PDE4 inhibitor (IC50 = 2 µM); inhibits t… |
25 mg |
18272-25 |
More Info
|
Ro 20-1724 |
A cell-permeable, selective PDE4 inhibitor (IC50 = 2 µM); inhibits t… |
50 mg |
18272-50 |
More Info
|
Ro 3280 |
A selective Plk1 inhibitor (IC50s = 3 and 6 nM in an enzymatic assay and H… |
1 mg |
21669-1 |
More Info
|
Ro 3280 |
A selective Plk1 inhibitor (IC50s = 3 and 6 nM in an enzymatic assay and H… |
10 mg |
21669-10 |
More Info
|
Ro 3280 |
A selective Plk1 inhibitor (IC50s = 3 and 6 nM in an enzymatic assay and H… |
25 mg |
21669-25 |
More Info
|
Ro 3280 |
A selective Plk1 inhibitor (IC50s = 3 and 6 nM in an enzymatic assay and H… |
5 mg |
21669-5 |
More Info
|
Ro 3306 |
A cell-permeable, reversible inhibitor of Cdk1, showing preference for Cdk… |
1 mg |
15149-1 |
More Info
|
Ro 3306 |
A cell-permeable, reversible inhibitor of Cdk1, showing preference for Cdk… |
10 mg |
15149-10 |
More Info
|
Ro 3306 |
A cell-permeable, reversible inhibitor of Cdk1, showing preference for Cdk… |
5 mg |
15149-5 |
More Info
|
Ro 3306 |
A cell-permeable, reversible inhibitor of Cdk1, showing preference for Cdk… |
50 mg |
15149-50 |
More Info
|
Ro 41-0960 |
A COMT inhibitor; prevents L-DOPA-induced dopaminergic neuron loss in prim… |
10 mg |
29621-10 |
More Info
|
Ro 41-0960 |
A COMT inhibitor; prevents L-DOPA-induced dopaminergic neuron loss in prim… |
25 mg |
29621-25 |
More Info
|
Ro 41-0960 |
A COMT inhibitor; prevents L-DOPA-induced dopaminergic neuron loss in prim… |
5 mg |
29621-5 |
More Info
|
Ro 48-8071 |
An oxidosqualene cyclase inhibitor with cholesterol lowering activity; inh… |
10 mg |
10006415-10 |
More Info
|
Ro 48-8071 |
An oxidosqualene cyclase inhibitor with cholesterol lowering activity; inh… |
100 mg |
10006415-100 |
More Info
|
Ro 48-8071 |
An oxidosqualene cyclase inhibitor with cholesterol lowering activity; inh… |
5 mg |
10006415-5 |
More Info
|
Ro 48-8071 |
An oxidosqualene cyclase inhibitor with cholesterol lowering activity; inh… |
50 mg |
10006415-50 |
More Info
|
Ro 4929097 |
A potent, selective inhibitor of γ-secretase (IC50 = 4 nM) that bloc… |
1 mg |
19996-1 |
More Info
|
Ro 4929097 |
A potent, selective inhibitor of γ-secretase (IC50 = 4 nM) that bloc… |
10 mg |
19996-10 |
More Info
|
Ro 4929097 |
A potent, selective inhibitor of γ-secretase (IC50 = 4 nM) that bloc… |
5 mg |
19996-5 |
More Info
|
Ro 4929097 |
A potent, selective inhibitor of γ-secretase (IC50 = 4 nM) that bloc… |
500 µg |
19996-500 |
More Info
|
Ro 5126766 |
A dual inhibitor of MEK1 (IC50 = 160 nM) and Raf kinases (IC50s = 56, 19,… |
1 mg |
29197-1 |
More Info
|
Ro 5126766 |
A dual inhibitor of MEK1 (IC50 = 160 nM) and Raf kinases (IC50s = 56, 19,… |
5 mg |
29197-5 |
More Info
|
Ro 60-0175 |
A 5-HT2 agonist; stimulates increases in intracellular calcium levels in C… |
1 mg |
29520-1 |
More Info
|
Ro 60-0175 |
A 5-HT2 agonist; stimulates increases in intracellular calcium levels in C… |
5 mg |
29520-5 |
More Info
|
Ro 61-8048 |
A potent inhibitor of kynurenine 3-hydroxylase (IC50 = 37 nM), preventing… |
10 mg |
15199-10 |
More Info
|
Ro 61-8048 |
A potent inhibitor of kynurenine 3-hydroxylase (IC50 = 37 nM), preventing… |
25 mg |
15199-25 |
More Info
|
Ro 61-8048 |
A potent inhibitor of kynurenine 3-hydroxylase (IC50 = 37 nM), preventing… |
5 mg |
15199-5 |
More Info
|
Ro 61-8048 |
A potent inhibitor of kynurenine 3-hydroxylase (IC50 = 37 nM), preventing… |
50 mg |
15199-50 |
More Info
|
Ro 67-4853 |
A selective, positive allosteric modulator of mGluR1, enhancing glutamate-… |
1 mg |
11992-1 |
More Info
|
Ro 67-4853 |
A selective, positive allosteric modulator of mGluR1, enhancing glutamate-… |
10 mg |
11992-10 |
More Info
|
Ro 67-4853 |
A selective, positive allosteric modulator of mGluR1, enhancing glutamate-… |
5 mg |
11992-5 |
More Info
|
Ro 67-7476 |
A positive allosteric modulator of mGluR1; enhances glutamate-induced calc… |
1 mg |
11993-1 |
More Info
|
Ro 67-7476 |
A positive allosteric modulator of mGluR1; enhances glutamate-induced calc… |
10 mg |
11993-10 |
More Info
|
Ro 67-7476 |
A positive allosteric modulator of mGluR1; enhances glutamate-induced calc… |
25 mg |
11993-25 |
More Info
|